AU-224

CAS No. 287399-47-7

AU-224( —— )

Catalog No. M33244 CAS No. 287399-47-7

AU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 411 In Stock
10MG 562 In Stock
25MG 866 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AU-224
  • Note
    Research use only, not for human use.
  • Brief Description
    AU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.
  • Description
    AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
  • In Vitro
    ——
  • In Vivo
    AU-224 has excellent effect of promoting digestive motion while showing little side effect and can be orally administered. AU-224 shows only weak gastrointestinal prokinetic activity after oral administration due to its low lipophilicity.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    287399-47-7
  • Formula Weight
    397.9
  • Molecular Formula
    C19H28ClN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCCCC)CN1CCC(NC(=O)C=2C=C(Cl)C(N)=CC2OC)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. WO/2000/046201A1
molnova catalog
related products
  • GnRH-I

    GnRH-I is a small 10 amino acid long peptide (decapeptide) from the hypothalamus,It is also known as luteinizing hormone releasing hormone (LHRH), is a key molecule in the regulation of reproduction in vertebrates. GnRH, a decapeptide, is produced by neurons in the medial basal hypothalamus (MBH) and secreted in a pulsatile manner into the cardiovascular system.

  • GSK-25

    GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).

  • H-Ser-Ser-Arg-Leu-Al...

    H-Ser-Ser-Arg-Leu-Ala-EDANS